Webb A T, Reaveley D A, O'Donnell M, O'Connor B, Seed M, Brown E A
Charing Cross and Westminister Medical School, Charing Cross Hospital, London, UK.
Nephrol Dial Transplant. 1993;8(7):609-13.
Lipoprotein (a) concentrations and apoprotein (a) isoforms were measured in 99 haemodialysis and 79 peritoneal dialysis patients and compared with a normal population. Peritoneal dialysis patients demonstrated a threefold and haemodialysis a twofold increase in median Lp(a) values compared to controls (P < or = 0.001). The peritoneal dialysis group had significantly more patients with Lp(a) values greater than 30 mg/dl compared to controls, (53% versus 22% P < or = 0.001). In addition both patient groups demonstrated significant hypertriglyceridaemia (P < or = 0.001), reduction in HDL (P < or = 0.001) and elevation of the cholesterol/HDL ratio (P < or = 0.001) compared with controls. Peritoneal dialysis patients also demonstrated significant hypercholesterolaemia (P < or = 0.003). Lipoprotein (a) concentrations are considerably elevated in patients on maintenance dialysis and this occurs in addition to the typical lipoprotein disturbances. This elevation may increase vascular risk, particularly in the peritoneal dialysis group who also have hypercholesterolaemia and reduced HDL.
对99例血液透析患者和79例腹膜透析患者测定了脂蛋白(a)浓度和载脂蛋白(a)异构体,并与正常人群进行比较。与对照组相比,腹膜透析患者的Lp(a)中位数增加了两倍,血液透析患者增加了一倍(P≤0.001)。与对照组相比,腹膜透析组Lp(a)值大于30mg/dl的患者明显更多(53%对22%,P≤0.001)。此外,与对照组相比,两组患者均表现出明显的高甘油三酯血症(P≤0.001)、高密度脂蛋白降低(P≤0.001)以及胆固醇/高密度脂蛋白比值升高(P≤0.001)。腹膜透析患者还表现出明显的高胆固醇血症(P≤0.003)。维持性透析患者的脂蛋白(a)浓度显著升高,且除了典型的脂蛋白紊乱外还会出现这种情况。这种升高可能会增加血管风险,尤其是在同时患有高胆固醇血症和高密度脂蛋白降低的腹膜透析组中。